<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD11640000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q9Y2J8</UniProt_ID>
  <Seq_Length>665</Seq_Length>
  <Molecule_Weight>75564</Molecule_Weight>
  <KEGG_ID>hsa:11240</KEGG_ID>
  <Orthology_ID>K01481</Orthology_ID>
  <Function_Summary>Catalyzes the deimination of arginine residues of proteins.</Function_Summary>
  <Catalytic_Mechanism>Protein L-arginine + H(2)O = protein L-citrulline + NH(3).</Catalytic_Mechanism>
  <Pfam_ID>PF03068:PAD@@PF08527:PAD_M@@PF08526:PAD_N</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Protein-arginine deiminase type II</Alias>
      <Alias>Peptidylarginine deiminase II</Alias>
      <Alias>PAD-H19</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an estrogen receptor.</Detail>
      <Keyword>Estrogen receptor binding</Keyword>
      <Ontology_ID>GO:0030331</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: protein L-arginine + H2O = protein L-citrulline + NH3.</Detail>
      <Keyword>Protein-arginine deiminase activity</Keyword>
      <Ontology_ID>GO:0004668</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with calcium ions (Ca2+).</Detail>
      <Keyword>Calcium ion binding</Keyword>
      <Ontology_ID>GO:0005509</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Maintenance of transcription by remodelling of chromatin into an 'open configuration'. Once established, this regulation is mitotically stable and is maintained over many cell divisions. It is also heritable.</Detail>
      <Keyword>Chromatin-mediated maintenance of transcription</Keyword>
      <Ontology_ID>GO:0048096</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The hydrolysis of peptidyl-arginine to form peptidyl-citrulline.</Detail>
      <Keyword>Peptidyl-citrulline biosynthetic process from peptidyl-arginine</Keyword>
      <Ontology_ID>GO:0018101</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of the substantia nigra over time from its initial formation until its mature state. The substantia nigra is the layer of gray substance that separates the posterior parts of the cerebral peduncles (tegmentum mesencephali) from the anterior parts; it normally includes a posterior compact part with many pigmented cells (pars compacta) and an anterior reticular part whose cells contain little pigment (pars reticularis).</Detail>
      <Keyword>Substantia nigra development</Keyword>
      <Ontology_ID>GO:0021762</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that decreases the rate, frequency or extent of the series of molecular events generated as a consequence of a chemokine binding to a cell surface receptor.</Detail>
      <Keyword>Negative regulation of chemokine-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0070100</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of chromatin disassembly. Chromatin disassembly is the controlled breakdown of chromatin from a higher order structure into its simpler subcomponents, DNA, histones, and other proteins.</Detail>
      <Keyword>Regulation of chromatin disassembly</Keyword>
      <Ontology_ID>GO:0010848</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of an estrogen binding to its receptor.</Detail>
      <Keyword>Estrogen receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0030520</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MLRERTVRLQYGSRVEAVYVLGTYLWTDVYSAAPAGAQTFSLKHSEHVWVEVVRDGEAEEVATNGKQRWLLSPSTTLRVTMSQASTEASSDKVTVNYYDEEGSIPIDQAGLFLTAIEISLDVDADRDGVVEKNNPKKASWTWGPEGQGAILLVNCDRETPWLPKEDCRDEKVYSKEDLKDMSQMILRTKGPDRLPAGYEIVLYISMSDSDKVGVFYVENPFFGQRYIHILGRRKLYHVVKYTGGSAELLFFVEGLCFPDEGFSGLVSIHVSLLEYMAQDIPLTPIFTDTVIFRIAPWIMTPNILPPVSVFVCCMKDNYLFLKEVKNLVEKTNCELKVCFQYLNRGDRWIQDEIEFGYIEAPHKGFPVVLDSPRDGNLKDFPVKELLGPDFGYVTREPLFESVTSLDSFGNLEVSPPVTVNGKTYPLGRILIGSSFPLSGGRRMTKVVRDFLKAQQVQAPVELYSDWLTVGHVDEFMSFVPIPGTKKFLLLMASTSACYKLFREKQKDGHGEAIMFKGLGGMSSKRITINKILSNESLVQENLYFQRCLDWNRDILKKELGLTEQDIIDLPALFKMDEDHRARAFFPNMVNMIVLDKDLGIPKPFGPQVEEECCLEMHVRGLLEPLGLECTFIDDISAYHKFLGEVHCGTNVRRKPFTFKWWHMVP</Protein_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Transcriptionally active chromatin</CellLocal>
      <Ontology_ID>GO:0035327</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular vesicular exosome</CellLocal>
      <Ontology_ID>GO:0070062</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>PADI2</Gene_Name>
    <Gene_Alias>KIAA0994; PDI2</Gene_Alias>
    <Gene_ID>11240</Gene_ID>
    <Genbank_ACCN>NM_007365</Genbank_ACCN>
    <Protein_ACCN>NP_031391</Protein_ACCN>
    <HGNC_ID>18341</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/11240</Gene_URL>
    <UCSC_ID>uc001baf.3</UCSC_ID>
    <EMBL_ID>ENSG00000117115</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Multiple Sclerosis</Disease_Name>
      <Disease_Detail>Multiple Sclerosis</Disease_Detail>
      <Disease_DB>MLT020</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/multiple_sclerosis?search=PADI2#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alzheimer's Disease</Disease_Name>
      <Disease_Detail>Alzheimer's Disease</Disease_Detail>
      <Disease_DB>ALZ001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alzheimers_disease?search=PADI2#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Model of Protein-arginine deiminase type-2</PDB_Title>
      <PDB_ID>ASD11640000_1</PDB_ID>
      <Resolution>-1.0</Resolution>
    </PDB>
  </PDB_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.5.3.15</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/5/3/15.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2015-04-08</Create_Date>
</Organism_Record>